Lucid Diagnostics Inc. Board of Directors

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Dr. Joseph Willis M.D.

Dr. Joseph Willis M.D.

Co-founder & Strategic Advisor

Dr. Brian J. deGuzman M.D.

Dr. Brian J. deGuzman M.D.

Chief Technology & Compliance Officer

Mr. Dennis M. McGrath CPA

Mr. Dennis M. McGrath CPA

Chief Financial Officer

Dr. Sanford D. Markowitz M.D., Ph.D.

Dr. Sanford D. Markowitz M.D., Ph.D.

Co-Founder & Strategic Advisor

Dr. Amitabh Chak M.D.

Dr. Amitabh Chak M.D.

Co-Founder & Strategic Advisor

Helen Moinova Ph.D.

Helen Moinova Ph.D.

Co-Founder & Strategic Advisor

Mr. Michael Adam Gordon

Mr. Michael Adam Gordon

General Counsel & Secretary

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.